Quantitative Description of Pharmacokinetics and Neopterin Response for Interferon-beta 1a

被引：0
|
作者：
Hu, Xiao
Li, Zhaoyang M.
Rogge, Mark
Zhu, Ying
Davar, Gudarz
Subramanyam, Meena
Nestorov, Ivan
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A598 / A598
页数：1
相关论文
共 50 条
  • [11] BIOCHEMICAL HOST RESPONSE TO INTERFERON-BETA
    LIBERATI, AM
    FIZZOTTI, M
    PROIETTI, MG
    DIMARZIO, R
    SCHIPPA, M
    BISCOTTINI, B
    SENATORE, M
    BERRUTO, P
    CANALI, S
    PERETTI, G
    ZANOLO, G
    JOURNAL OF INTERFERON RESEARCH, 1988, 8 (06): : 765 - 777
  • [12] Side effects of interferon-beta 1a in relapsing-remitting multiple sclerosis
    Lotfi, J
    Adibnejad, S
    Beheshtian, A
    JOURNAL OF NEUROLOGY, 2004, 251 : 64 - 64
  • [13] PHARMACOKINETICS OF HUMAN RECOMBINANT INTERFERON-BETA IN MONKEYS AND RABBITS
    GOMI, K
    MORIMOTO, M
    INOUE, A
    KOBAYASHI, H
    DEGUCHI, T
    HARA, T
    NAKAMIZO, N
    GANN, 1984, 75 (03): : 292 - 300
  • [14] Interferon-beta 1a in der Therapie der schubförmigen multiplen Sklerose
    H.-P. Hartung
    Reinhard Hohlfeld
    Der Nervenarzt, 1997, 68 : 525 - 527
  • [15] A comparative study of development of anti-interferon-beta antibodies in a randomized study of interferon-beta 1b and interferon beta 1a in patients with multiple sclerosis
    Sorensen, PS
    Ross, C
    Koch-Henriksen, N
    Svenson, M
    Skovgaard, GL
    Bendtzen, K
    NEUROLOGY, 1999, 52 (06) : A491 - A491
  • [16] A randomized controlled trial of recombinant interferon-beta 1a in Guillain-Barre syndrome
    Pritchard, J
    Gray, IA
    Idrissova, ZR
    Lecky, BRF
    Sutton, IJ
    Swan, AV
    Willison, HJ
    Winer, JB
    Hughes, RAC
    NEUROLOGY, 2003, 61 (09) : 1282 - 1284
  • [17] A comparison of the rate of switched and discontinued therapy between interferon-beta 1A preparations.
    O'Rourke, K
    Hutchinson, M
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (08): : 1225 - 1225
  • [18] Comparison of pharmacokinetic and pharmacodynamic data of interferon-beta 1a preparations following intramuscular and subcutaneous administration
    Gruber, R
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1998, 48 (10): : 1043 - 1046
  • [19] Cutaneous vasculitis with renal impairment complicating interferon-beta 1a therapy for multiple sclerosis.
    Zoguéreh, DD
    Boucraut, J
    Beau-Salinas, F
    Bodiguel, E
    Lechapois, D
    Pomet, E
    REVUE NEUROLOGIQUE, 2004, 160 (11) : 1081 - 1084
  • [20] Interferon-Beta 1a Modulation of B-Cell Costimulatory Function: Implications for Multiple Sclerosis
    Huang, Hui
    Ito, Kouichi
    Dhib-Jalbut, Suhayl
    NEUROLOGY, 2011, 76 (09) : A134 - A134
12345